Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients

Clinical trial NCT02117518 · UNKNOWN

Trial details

NCT number: NCT02117518
Sponsor: Migal Galilee Research Institute
Status: UNKNOWN
Study type: OBSERVATIONAL

Type I Diabetes

Start date: 2014-05-01
Primary completion: 2015-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.